To sustain a healthy population in our modern world, we need novel therapies.
Our research covers modern drug discovery across the spectrum of neuroscience, mental health and cancer.
The Organisation for Economic Co-operation and Development estimates the economic cost of mental health conditions in the UK at £70 to £100 billion each year. By optimising therapies, we can make a real impact on the lives of patients and the healthcare sector.
Our research is discovering novel therapeutic options for mental health conditions including schizophrenia and anxiety.
Our research is carried out by a multidisciplinary team of experts, so that we can meet the biggest health challenges of our time.
Scientists within our Institute work together with collaborators from across the University, as well as with industry, to bring cutting-edge biomedical science from the laboratory bench to the patient’s bedside.
Through our research, we aim to deliver new and innovative treatments for neurological conditions such as Huntington’s disease and fragile X.
Despite advancements in the treatments of cancer and improvements in five-year survival rates, we still do not have effective therapies for all tumours.
We have a well-established portfolio of projects focusing on bettering cancer treatments. We are working on developing and identifying effective cancer targets to produce personalised cancer treatments – reducing side effects and improving outcomes for people with cancer.